Clinical Pharmacokinetics: cram pack

Formula sheets, the key method steps for every topic and 8 practice problems, with full solutions at the back.

New problemsBack to the course

In the print window, choose “Save as PDF” to keep a copy on your device.

1Formulas and methods

Clinical pharmacokinetics

Rate constant and half-life
k = ln 2/t½ = 0.693/t½
First-order decay
C = C₀·e−kt = C₀·(1/2)t/t½
Two levels
k = ln(C₁/C₂)/Δt
Volume and clearance
Vd = dose/C₀, CL = k·Vd
Loading dose
LD = Vd·C/(S·F)
Maintenance rate
R = CL·Css/(S·F)
Average steady state
Css,avg = S·F·D/(CL·τ)
Steady state
1 − (1/2)ⁿ after n half-lives; ≈ 97% after 5
Infusion
C = (R/CL)(1 − e−kt)
Interval and dose from peak and trough
τ = ln(Cpeak/Ctrough)/k, D = Vd·(Cpeak − Ctrough)
Cockcroft–Gault
CrCl = (140 − age) × kg/(72 × SCr mg/dL), × 0.85 for women
Renal adjustment
dose × CrCl/normal; Dettli Q = 1 − fe·(1 − CrCl/normal)

Method

  1. Convert the half-life to a rate constant: k = 0.693/t½.
  2. Turn per-kg values into totals: Vd (L) = L/kg × weight, CL (L/h) = L/kg/h × weight.
  3. Pick the relation: C = C₀·e−kt, LD = Vd·C/(S·F), maintenance rate = CL·Css/(S·F), τ = ln(Cpeak/Ctrough)/k.
  4. For kidney function, estimate CrCl with Cockcroft–Gault first, then scale the dose or the interval.
  5. Check the result: levels fall by half every half-life, and steady state takes about five half-lives.

Pharmacy calculations

Percentage strength
% w/v = g per 100 mL
Amount in a solution
g = % × mL / 100
Ratio strength
1:X = 1 g in X mL; % = 100 / X
Reconstitution
final volume = diluent + powder volume
Concentration
mg/mL = drug in vial / final volume
Alligation
parts of H = T − L, parts of L = H − T
Water or base
0%

Pediatric & critical-care dosing

Daily dose
mg/day = mg/kg/day × weight (kg)
Doses per day
number = 24 h / dosing interval (h)
Pounds to kilograms
kg = lb / 2.2
Infusion concentration
units/mL = units in bag / bag volume
Pump rate
mL/h = dose per hour / concentration
Titrated drip
mL/h = mcg/kg/min × kg × 60 / (mcg/mL)
Dose from pump rate
mcg/kg/min = mL/h × (mcg/mL) / (60 × kg)
Units
1 mg = 1000 mcg

2Practice problems

1.Clinical pharmacokineticsMedium
110100t (h)C (mg/L)2 h9 mg/L10 h1.8 mg/L

Practice exercise (made-up values, not clinical guidance). After an IV dose of gentamicin, the level is 9 mg/L at 2 h and 1.8 mg/L at 10 h. Assume first-order elimination. Find the half-life t½.

C1 = 9 mg/L (2 h)C2 = 1.8 mg/L (10 h)
t½ = h
2.Clinical pharmacokineticsHard
VCss,avg​ = ?300 mg · q12hCL = 0.045 L/kg/h97 kg · S = 1 · F = 1

Practice exercise (made-up values, not clinical guidance). A 97 kg patient takes oral theophylline (F = 1) every 12 h. The clearance is 0.045 L/kg/h. Each dose is 300 mg of theophylline. Find the average steady-state level Css,avg.

CL = 0.045 L/kg/hτ = 12 hS = 1F = 197 kgD = 300 mg
Css,avg = mg/L
3.Pharmacy calculationsMedium
00.10.20.30.40.50.60.70.80.911 mL

A solution has a ratio strength of 1:1000. You need 0.71 mg. Draw up the volume in the 1 mL syringe: what volume V is that?

1:10000.71 mg
V = mL
4.Pharmacy calculationsHard
0123455 mL

A vial holds 2000 mg of powder. You add 4.6 mL of diluent, and the powder adds 0.4 mL of volume. The prescription is 600 mg. Draw up the dose: what volume V do you give?

2000 mg4.6 mL + 0.4 mL600 mg
V = mL
5.Pediatric & critical-care dosingMedium
25 000 units250 mLheparin? mL/h83 kg12 units/kg/h

Practice exercise (made-up values, not clinical guidance). A bag contains 25 000 units of heparin in 250 mL. The order is 12 units/kg/h for a patient who weighs 83 kg. At what rate R do you set the pump, in mL/h? Round to one decimal place.

25 000 units/250 mL12 units/kg/h83 kg
R = mL/h
6.Pediatric & critical-care dosingHard
500 mg250 mLdobutamine? mL/h108 kg5 mcg/kg/min

Practice exercise (made-up values, not clinical guidance). A bag contains dobutamine 500 mg in 250 mL. The order is 5 mcg/kg/min for a patient who weighs 108 kg. At what rate R do you set the pump, in mL/h? Round to one decimal place.

500 mg/250 mL5 mcg/kg/min108 kg
R = mL/h
7.PharmacologyMedium

Why is aspirin avoided in children and teenagers with viral illnesses such as flu or chickenpox?

  1. AIt stops the vaccine from working
  2. BIt causes severe, permanent hearing loss in young children
  3. CIt causes grey baby syndrome
  4. DIt is linked to Reye's syndrome, which harms the liver and brain
8.PharmacologyHard

Before starting rituximab, patients are tested for hepatitis B. Why?

  1. ARituximab is made from the hepatitis B virus
  2. BRituximab is a vaccine against hepatitis B
  3. CHepatitis B infection makes rituximab completely ineffective
  4. DRituximab can reactivate hepatitis B and cause liver failure

3Solutions

1.Clinical pharmacokinetics

Answer: t½ = 3.445 h

Clearance and volume: at steady state the dosing rate equals the elimination rate, so the maintenance rate = CL × Css. A loading dose is LD = Vd × C/(S × F), with S the salt factor (fraction of active drug in the salt) and F the bioavailability (1 for IV). From two levels, k = ln(C₁/C₂)/Δt; for an IV bolus Vd = dose/C₀ and CL = k × Vd. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.

Elimination rate constant

k = ln(9/1.8)/8 = 1.609/8 = 0.2012 h⁻¹

Half-life

t½ = 0.693/0.2012 = 3.445 h

Answer

t½ = 3.445 h
2.Clinical pharmacokinetics

Answer: Css,avg = 5.727 mg/L

Designing a regimen: with rapid IV doses the level falls from peak to trough during the interval, so τ = ln(Cpeak/Ctrough)/k and the dose that restores the peak is Vd × (Cpeak − Ctrough). The average steady-state level is Css,avg = S·F·dose/(CL·τ). An infusion rises as C = (R/CL)(1 − e−kt). For a drug cleared by the kidneys, the dose is scaled with the creatinine clearance. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.

Clearance

CL = 0.045·97 = 4.365 L/h

Average steady-state level

Css,avg = S·F·D/(CL·τ) = 1·1·300/(4.365·12) = 5.727 mg/L

Answer

Css,avg = 5.727 mg/L
3.Pharmacy calculations

Answer: V = 0.71 mL

Strength to volume: turn the strength into mg per mL first. A w/v percentage is grams per 100 mL, so x% = 10x mg/mL. A ratio strength 1:n is 1 g in n mL. After reconstitution the concentration is the powder's dose over the final volume (diluent + powder volume). Then volume = dose/concentration.

Strength in mg/mL

1000 mg/1000 mL = 1 mg/mL

Volume

V = 0.71/1 = 0.71 mL

Answer

V = 0.71 mL
4.Pharmacy calculations

Answer: V = 1.5 mL

Strength to volume: turn the strength into mg per mL first. A w/v percentage is grams per 100 mL, so x% = 10x mg/mL. A ratio strength 1:n is 1 g in n mL. After reconstitution the concentration is the powder's dose over the final volume (diluent + powder volume). Then volume = dose/concentration.

Final volume and concentration

4.6 + 0.4 = 5 mL
C = 2000/5 = 400 mg/mL

Volume

V = 600/400 = 1.5 mL

Answer

V = 1.5 mL
5.Pediatric & critical-care dosing

Answer: R = 10 mL/h

Heparin and insulin infusions: concentration = units in the bag/bag volume (units/mL). Pump rate (mL/h) = units per hour/concentration, and units per hour = mL/h × concentration. For a weight-based order, units/h = units/kg/h × weight first. A bolus volume = units needed/vial strength. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.

Units per hour

12·83 = 996 units/h

Concentration

25 000/250 = 100 units/mL

Pump rate

R = 996/100 = 9.96 ≈ 10 mL/h

Answer

R = 10 mL/h
6.Pediatric & critical-care dosing

Answer: R = 16.2 mL/h

Titrated drips: first find the concentration in mcg/mL (mg × 1000/mL). For a weight-based order, mcg/min = mcg/kg/min × weight. Then mL/h = mcg/min × 60/concentration. Working backwards, mcg/kg/min = mL/h × concentration/(60 × weight). The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.

Concentration

500 mg = 500 000 mcg
500 000/250 = 2000 mcg/mL

Dose per minute and per hour

5·108 = 540 mcg/min
540·60 = 32400 mcg/h

Pump rate

R = 32400/2000 = 16.2 mL/h

Answer

R = 16.2 mL/h
7.Pharmacology

Answer: D · It is linked to Reye's syndrome, which harms the liver and brain

Why this is the answer

Aspirin given during viral infections in young people is associated with Reye's syndrome, causing acute encephalopathy and liver failure. Paracetamol or ibuprofen is used for fever instead.

Answer

D · It is linked to Reye's syndrome, which harms the liver and brain
8.Pharmacology

Answer: D · Rituximab can reactivate hepatitis B and cause liver failure

Why this is the answer

Rituximab destroys CD20-positive B cells, weakening control of latent hepatitis B. Reactivation can cause fulminant hepatitis, so carriers receive monitoring or antiviral prophylaxis.

Answer

D · Rituximab can reactivate hepatitis B and cause liver failure

ExamProblems · examproblems.com/courses/clinical-pharmacokinetics